XML 121 R107.htm IDEA: XBRL DOCUMENT v3.22.1
Financial instruments - Narrative (Details)
$ in Thousands
24 Months Ended
Jan. 07, 2022
USD ($)
Mar. 31, 2022
USD ($)
CAD ($)
Mar. 31, 2021
USD ($)
CAD ($)
Mar. 31, 2020
USD ($)
Jan. 07, 2020
USD ($)
Disclosure of detailed information about financial instruments [line items]          
Cash and cash equivalents   $ 953,654 $ 807,150 $ 210,969  
Undrawn borrowing facilities   $ 25,000      
Nominal amount of hedging instrument   26,000,000 0    
Level 3 | Contingent consideration          
Disclosure of detailed information about financial instruments [line items]          
Financial liabilities, at fair value     $ 0    
Equity price risk          
Disclosure of detailed information about financial instruments [line items]          
10% change in the ordinary share price of the company, impact on accrual for social costs   $ 527      
Gastrofix          
Disclosure of detailed information about financial instruments [line items]          
Contingent consideration recognised as of acquisition date         $ 0
Gastrofix | Level 3          
Disclosure of detailed information about financial instruments [line items]          
Financial liabilities, at fair value $ 0        
Gastrofix | Forecast          
Disclosure of detailed information about financial instruments [line items]          
Maximum amount of potential contingent consideration payable $ 10,030